Reforming Medicare payments for Part B drugs

Joseph Antos and James Capretta
Additional contact information
James Capretta: American Enterprise Institute

AEI Economic Perspectives, 2019

Abstract: The Trump administration has proposed a test of a new Medicare Part B payment system for drugs administered in physician offices and hospital outpatient clinics. The effect of this policy is an arbitrary payment cut. Joseph Antos and James C. Capretta propose an alternative market-based approach.

Keywords: Medicare; pharmaceuticals; AEI Economic Perspectives (search for similar items in EconPapers)
JEL-codes: A (search for similar items in EconPapers)
Date: 2019
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.aei.org/wp-content/uploads/2019/06/Ref ... t-B-Drugs.pdf?x91208 (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:aei:journl:y:2019:id:1018985

Access Statistics for this article

More articles in AEI Economic Perspectives from American Enterprise Institute Contact information at EDIRC.
Bibliographic data for series maintained by Dave Adams, CIO ().